Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels-Reference-Cited by-同舟云学术

Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels

Published:2017-10 Issue:10 Volume:37 Page:1241-1248
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Wahby Krista A.¹,Riley Lauren K.²,Tennenberg Steven D.³

Affiliation:

1. Department of Pharmacy; Harper University Hospital; Detroit Michigan

2. Department of Pharmacy; Detroit Receiving Hospital; Detroit Michigan

3. Department of Surgery; Wayne State University School of Medicine; Detroit Michigan

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.2014/fullpdf

Reference28 articles.

1. Antithrombotic treatment and prevention of thrombosis, 9th Edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Guyatt;Chest,2012

2. Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis;Arabi;Chest,2013

3. Venous thromboembolism in patients with renal insufficiency: findings from the REITE registry;Monreal;Am J Med,2006

4. Thrombosis prophylaxis and mortality risk among critically ill adults;Lilly;Chest,2014

5. Fondaparinux sodium. a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery;Reynolds;Drugs,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report;Frontiers in Medicine;2023-02-23

2. Disordered Hemostasis and Renal Disorders;Pediatric Kidney Disease;2023

3. Fondaparinux is an effective alternative to other non-heparin anticoagulants in the treatment of heparin-induced thrombocytopenia;Clinical Research In Practice: The Journal of Team Hippocrates;2019-10-01

4. Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill;Thrombosis Journal;2019-04-15